RAŠKA, Filip, Břetislav LIPOVÝ, Jakub HOLOUBEK, Š. KOBZOVÁ, Lukáš VACEK, L. VOJTOVÁ and L. JANDA. Promising effect of topical antimicrobial ‘biobetters’ against methicillin-resistant Staphylococcus aureus strains. Burns. OXON: ELSEVIER SCI LTD, 2022, vol. 48, No 7, p. 1770-1772. ISSN 0305-4179. Available from: https://dx.doi.org/10.1016/j.burns.2022.08.011.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Promising effect of topical antimicrobial ‘biobetters’ against methicillin-resistant Staphylococcus aureus strains
Authors RAŠKA, Filip (203 Czech Republic, belonging to the institution), Břetislav LIPOVÝ (203 Czech Republic, belonging to the institution), Jakub HOLOUBEK (203 Czech Republic, belonging to the institution), Š. KOBZOVÁ (203 Czech Republic), Lukáš VACEK (203 Czech Republic, belonging to the institution), L. VOJTOVÁ and L. JANDA (203 Czech Republic).
Edition Burns, OXON, ELSEVIER SCI LTD, 2022, 0305-4179.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30212 Surgery
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 2.700
RIV identification code RIV/00216224:14110/22:00127028
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1016/j.burns.2022.08.011
UT WoS 000880116100012
Keywords in English topical antimicrobial 'biobetters'; methicillin-resistant Staphylococcus aureus strains
Tags 14110113, 14110229, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 16/1/2023 13:36.
Abstract
Successful control of burn wound infection is one of the keystones in the successful treatment of patients with burn injury. The increase in the prevalence of resistant strains of pathogens dramatically reduces the options of antibiotic treatment. Infectious complications caused by methicillin-resistant Staphylococcus aureus (MRSA) are known to be associated with significantly higher mortality than those caused by methicillin-sensitive strains (MSSA; 42 % and 18 %, respectively). This situation underlines the necessity for other strategies to control infectious complications of burn wounds. The use of enzybiotics (such as endolysins and lysostaphins), specific products of bacteriophages or competing bacteria, appears to be a promising alternative approach. Their advantages include high specificity and, in particular, they appear less susceptible to the development of resistant strains of bacteria. The principal limitations of the current options for the use of enzybiotics in the topical treatment of MRSA-induced burn wound infections are 1) low production associated with a high price, 2) short duration of the enzymatic activity, which is caused by the structural instability of enzymes resulting in protein denaturation and 3) low resistance of the enzyme to proteases – in particular, matrix metalloproteinases (MMPs), which are produced in the burn wound area in high amounts.
PrintDisplayed: 26/8/2024 15:58